The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
T-cell inflamed phenotype and PDL1 expression in malignant mesothelioma.
Hedy Lee Kindler
Consultant or Advisory Role - AstraZeneca; MedImmune; Roche/Genentech; Verastem
Zhixiang Zuo
No relevant relationships to disclose
Arun Khattri
No relevant relationships to disclose
Michaela K. Keck
No relevant relationships to disclose
Wickii Vigneswaran
No relevant relationships to disclose
Aliya Noor Husain
No relevant relationships to disclose
Tanguy Y. Seiwert
Consultant or Advisory Role - Bayer/Onyx; Boehringer Ingelheim; Novartis
Research Funding - Boehringer Ingelheim; Genentech